Healthcare U.S. Molecular Diagnostics Markets

 

INDUSTRY
Healthcare

RELEASE DATE
15-Sep-2004
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
F131-01-00-00-00
SKU
HC01413-NA-MR_05860
Yes
SHARE

U.S. Molecular Diagnostics Markets
Published on: 15-Sep-2004 | SKU: HC01413-NA-MR_05860

Need more details?

$2,450.00

$1,837.50 save 25 %

DownloadLink
Need more details?

The study provides a U.S. market scenario for molecular diagnostics markets. The markets are divided as Infectious diseases, cancer, and pharmacogenomics markets. Emerging markets in molecular diagnostics are also discussed. Product analysis and technology analysis are detailed in the study. The study provides competitive position of key market participants. Frost & Sullivan awards are bestowed to well deserving companies in the industry.

Executive Summary

  • Executive Summary

Overview

  • Introduction
  • Research Methodology

Market Forecasts

  • Overview
  • Market Segment Overview
  • Revenue Forecasts

Competitive Landscape

  • Market Share Analysis
  • Product Analysis

Challenges and Strategies

  • Industry Challenges
  • Strategic Recommendations

Frost & Sullivan Awards

  • Product Innovation Award
  • Technology Innovation Award
  • Technology Leadership Award
  • Product Launch Strategy Award

Overview

Market Dynamics

Market Forecasts

Competitive Landscape

Emerging Markets - West Nile Virus

  • Introduction
  • Market Engineering Analysis

Overview

Market Dynamics

Market Forecasts

Competitive Landscape

Overview

Market Dynamics

Market Forecasts

Competitive Landscape

Emerging Markets - HCV Genotyping

Decision Support Databases


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The study provides a U.S. market scenario for molecular diagnostics markets. The markets are divided as Infectious diseases, cancer, and pharmacogenomics markets. Emerging markets in molecular diagnostics are also discussed. Product analysis and technology analysis are detailed in the study. The study provides competitive position of key market participants. Frost & Sullivan awards are bestowed to well deserving companies in the industry.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number F131-01-00-00-00
Is Prebook No

U.S. Molecular Diagnostics Markets

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC01413-NA-MR_05860